These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19610324)

  • 1. Comment on "An experimental palladium-103 seed (OptiSeedexp in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect" [Med. Phys. 35, 5841-5850 (2008)].
    Pignol JP; Keller BM
    Med Phys; 2009 Jun; 36(6):2343; author reply 2344. PubMed ID: 19610324
    [No Abstract]   [Full Text] [Related]  

  • 2. An experimental palladium-103 seed (OptiSeedexp) in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect.
    Abboud F; Scalliet P; Vynckier S
    Med Phys; 2008 Dec; 35(12):5841-50. PubMed ID: 19175140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric study of a new polymer encapsulated palladium-103 seed.
    Bernard S; Vynckier S
    Phys Med Biol; 2005 Apr; 50(7):1493-504. PubMed ID: 15798339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monte Carlo and experimental characterization of the first AMIRS 103Pd brachytherapy source.
    Raisali G; Ghonchehnazi MG; Shokrani P; Sadeghi M
    Appl Radiat Isot; 2008 Dec; 66(12):1856-60. PubMed ID: 18657981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
    Chibani O; Williamson JF; Todor D
    Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monte Carlo-aided dosimetry of the theragenics TheraSeed model 200 103Pd interstitial brachytherapy seed.
    Monroe JI; Williamson JF
    Med Phys; 2002 Apr; 29(4):609-21. PubMed ID: 11991133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on "Update of AAPM Task Group no. 43 report: A revised AAPM protocol for brachytherapy dose calculations" [Med. Phys. 31, 633-674 (2004)].
    Meigooni AS; Rachabatthula V; Awan SB; Koona RA
    Med Phys; 2005 Jun; 32(6):1820-1; author reply 1822-4. PubMed ID: 16013739
    [No Abstract]   [Full Text] [Related]  

  • 9. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
    Lesperance M; Martinov M; Thomson RM
    Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of dose heterogeneity on the biological efficiency of ¹⁰³Pd permanent breast seed implants.
    Afsharpour H; Reniers B; Landry G; Pignol JP; Keller BM; Verhaegen F; Beaulieu L
    Phys Med Biol; 2012 Feb; 57(3):809-23. PubMed ID: 22252246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo study of LDR seed dosimetry with an application in a clinical brachytherapy breast implant.
    Furstoss C; Reniers B; Bertrand MJ; Poon E; Carrier JF; Keller BM; Pignol JP; Beaulieu L; Verhaegen F
    Med Phys; 2009 May; 36(5):1848-58. PubMed ID: 19544804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to "Comment on 'AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137'" [Med. Phys. 36, 5310-5322 (2009)].
    Nath R; Bice WS; Butler WM; Chen Z; Meigooni AS; Narayana V; Rivard MJ; Yu Y
    Med Phys; 2010 Apr; 37(4):1933. PubMed ID: 20443515
    [No Abstract]   [Full Text] [Related]  

  • 13. Monte Carlo and experimental dosimetry of an 1251 brachytherapy seed.
    Dolan J; Lia Z; Williamson JF
    Med Phys; 2006 Dec; 33(12):4675-84. PubMed ID: 17278820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental and theoretical dosimetry of a new polymer encapsulated iodine-125 source--SmartSeed: dosimetric impact of fluorescence x rays.
    Abboud F; Hollows M; Scalliet P; Vynckier S
    Med Phys; 2010 May; 37(5):2054-62. PubMed ID: 20527538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer gel dosimetry for the TG-43 dosimetric characterization of a new 125I interstitial brachytherapy seed.
    Papagiannis P; Pantelis E; Georgiou E; Karaiskos P; Angelopoulos A; Sakelliou L; Stiliaris S; Baltas D; Seimenis I
    Phys Med Biol; 2006 Apr; 51(8):2101-11. PubMed ID: 16585848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric parameters of the new design (103)Pd brachytherapy source based on Monte Carlo study.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Phys Med; 2012 Jan; 28(1):13-8. PubMed ID: 21251862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
    Thomson RM; Taylor RE; Rogers DW
    Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric characterization of model Cs-1 Rev2 cesium-131 brachytherapy source in water phantoms and human tissues with MCNP5 Monte Carlo simulation.
    Wang J; Zhang H
    Med Phys; 2008 Apr; 35(4):1571-9. PubMed ID: 18491551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Med Phys; 2010 Jun; 37(6):2509-15. PubMed ID: 20632562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.